APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ringworm Treatment Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ringworm Treatment Drugs Market Outlook and Growth Opportunities 2026

21 December 2025193 pages

Choose your research edition.

Industry ResearchRingworm Treatment Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Ringworm Treatment Drugs Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Ringworm Treatment Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ringworm Treatment Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Ringworm Treatment Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Ringworm Treatment Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ringworm Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ringworm Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ringworm Treatment Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ringworm Treatment Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ringworm Treatment Drugs market include Teva Pharmaceuticals, Inc., Novartis AG, Merck & Co., In, GlaxoSmithKline Plc, Taro Ppharmaceutical Industries Ltd., Perrigo Company plc, Glenmark Pharmaceuticals Inc., Chempro Group India and Avik Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ringworm Treatment Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ringworm Treatment Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ringworm Treatment Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ringworm Treatment Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Ringworm Treatment Drugs Segment by Company

Teva Pharmaceuticals, Inc.

Novartis AG

Merck & Co., In

GlaxoSmithKline Plc

Taro Ppharmaceutical Industries Ltd.

Perrigo Company plc

Glenmark Pharmaceuticals Inc.

Chempro Group India

Avik Pharma

Actiza Pharmaceutical

Ringworm Treatment Drugs Segment by Type

Anti-infective

Antifungals

Steroids

Others

Ringworm Treatment Drugs Segment by Application

Hospital Pharmacies

Drug Stores

E-commerce

Other

Ringworm Treatment Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Ringworm Treatment Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Ringworm Treatment Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ringworm Treatment Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Ringworm Treatment Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ringworm Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ringworm Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ringworm Treatment Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ringworm Treatment Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ringworm Treatment Drugs industry.

Chapter 3: Detailed analysis of Ringworm Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Ringworm Treatment Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Ringworm Treatment Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ringworm Treatment Drugs Industry Trends Table 2. Ringworm Treatment Drugs Industry Drivers Table 3. Ringworm Treatment Drugs Industry Opportunities and Challenges Table 4. Ringworm Treatment Drugs Industry Restraints Table 5. Global Ringworm Treatment Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ringworm Treatment Drugs Revenue Share by Company (2021-2026) Table 7. Global Ringworm Treatment Drugs Sales Volume by Company (k units) & (2021-2026) Table 8. Global Ringworm Treatment Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Ringworm Treatment Drugs Average Price (US$/unit) of Company (2021-2026) Table 10. Global Ringworm Treatment Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Ringworm Treatment Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Ringworm Treatment Drugs Company, Product Type & Application Table 13. Global Ringworm Treatment Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Ringworm Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Anti-infective Table 18. Significant Companies of Antifungals Table 19. Significant Companies of Steroids Table 20. Significant Companies of Others Table 21. Global Ringworm Treatment Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Ringworm Treatment Drugs Sales Volume by Type (2021-2026) & (k units) Table 23. Global Ringworm Treatment Drugs Sales Volume by Type (2027-2032) & (k units) Table 24. Global Ringworm Treatment Drugs Sales Volume Share by Type (2021-2026) Table 25. Global Ringworm Treatment Drugs Sales Volume Share by Type (2027-2032) Table 26. Global Ringworm Treatment Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Ringworm Treatment Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Ringworm Treatment Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Ringworm Treatment Drugs Sales Value Share by Type (2021-2026) Table 30. Global Ringworm Treatment Drugs Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Pharmacies Table 32. Significant Companies of Drug Stores Table 33. Significant Companies of E-commerce Table 34. Significant Companies of Other Table 35. Global Ringworm Treatment Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Ringworm Treatment Drugs Sales Volume by Application (2021-2026) & (k units) Table 37. Global Ringworm Treatment Drugs Sales Volume by Application (2027-2032) & (k units) Table 38. Global Ringworm Treatment Drugs Sales Volume Share by Application (2021-2026) Table 39. Global Ringworm Treatment Drugs Sales Volume Share by Application (2027-2032) Table 40. Global Ringworm Treatment Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Ringworm Treatment Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Ringworm Treatment Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Ringworm Treatment Drugs Sales Value Share by Application (2021-2026) Table 44. Global Ringworm Treatment Drugs Sales Value Share by Application (2027-2032) Table 45. Global Ringworm Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Ringworm Treatment Drugs Sales by Region (2021-2026) & (k units) Table 47. Global Ringworm Treatment Drugs Sales Market Share by Region (2021-2026) Table 48. Global Ringworm Treatment Drugs Sales by Region (2027-2032) & (k units) Table 49. Global Ringworm Treatment Drugs Sales Market Share by Region (2027-2032) Table 50. Global Ringworm Treatment Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Ringworm Treatment Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Ringworm Treatment Drugs Sales Value Share by Region (2021-2026) Table 53. Global Ringworm Treatment Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Ringworm Treatment Drugs Sales Value Share by Region (2027-2032) Table 55. Global Ringworm Treatment Drugs Market Average Price (US$/unit) by Region (2021-2026) Table 56. Global Ringworm Treatment Drugs Market Average Price (US$/unit) by Region (2027-2032) Table 57. Global Ringworm Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global Ringworm Treatment Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Ringworm Treatment Drugs Sales by Country (2021-2026) & (k units) Table 60. Global Ringworm Treatment Drugs Sales Market Share by Country (2021-2026) Table 61. Global Ringworm Treatment Drugs Sales by Country (2027-2032) & (k units) Table 62. Global Ringworm Treatment Drugs Sales Market Share by Country (2027-2032) Table 63. Global Ringworm Treatment Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Ringworm Treatment Drugs Sales Value Market Share by Country (2021-2026) Table 65. Global Ringworm Treatment Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Ringworm Treatment Drugs Sales Value Market Share by Country (2027-2032) Table 67. Teva Pharmaceuticals, Inc. Company Information Table 68. Teva Pharmaceuticals, Inc. Business Overview Table 69. Teva Pharmaceuticals, Inc. Ringworm Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Teva Pharmaceuticals, Inc. Ringworm Treatment Drugs Product Portfolio Table 71. Teva Pharmaceuticals, Inc. Recent Development Table 72. Novartis AG Company Information Table 73. Novartis AG Business Overview Table 74. Novartis AG Ringworm Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Novartis AG Ringworm Treatment Drugs Product Portfolio Table 76. Novartis AG Recent Development Table 77. Merck & Co., In Company Information Table 78. Merck & Co., In Business Overview Table 79. Merck & Co., In Ringworm Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Merck & Co., In Ringworm Treatment Drugs Product Portfolio Table 81. Merck & Co., In Recent Development Table 82. GlaxoSmithKline Plc Company Information Table 83. GlaxoSmithKline Plc Business Overview Table 84. GlaxoSmithKline Plc Ringworm Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. GlaxoSmithKline Plc Ringworm Treatment Drugs Product Portfolio Table 86. GlaxoSmithKline Plc Recent Development Table 87. Taro Ppharmaceutical Industries Ltd. Company Information Table 88. Taro Ppharmaceutical Industries Ltd. Business Overview Table 89. Taro Ppharmaceutical Industries Ltd. Ringworm Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Taro Ppharmaceutical Industries Ltd. Ringworm Treatment Drugs Product Portfolio Table 91. Taro Ppharmaceutical Industries Ltd. Recent Development Table 92. Perrigo Company plc Company Information Table 93. Perrigo Company plc Business Overview Table 94. Perrigo Company plc Ringworm Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Perrigo Company plc Ringworm Treatment Drugs Product Portfolio Table 96. Perrigo Company plc Recent Development Table 97. Glenmark Pharmaceuticals Inc. Company Information Table 98. Glenmark Pharmaceuticals Inc. Business Overview Table 99. Glenmark Pharmaceuticals Inc. Ringworm Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Glenmark Pharmaceuticals Inc. Ringworm Treatment Drugs Product Portfolio Table 101. Glenmark Pharmaceuticals Inc. Recent Development Table 102. Chempro Group India Company Information Table 103. Chempro Group India Business Overview Table 104. Chempro Group India Ringworm Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Chempro Group India Ringworm Treatment Drugs Product Portfolio Table 106. Chempro Group India Recent Development Table 107. Avik Pharma Company Information Table 108. Avik Pharma Business Overview Table 109. Avik Pharma Ringworm Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Avik Pharma Ringworm Treatment Drugs Product Portfolio Table 111. Avik Pharma Recent Development Table 112. Actiza Pharmaceutical Company Information Table 113. Actiza Pharmaceutical Business Overview Table 114. Actiza Pharmaceutical Ringworm Treatment Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Actiza Pharmaceutical Ringworm Treatment Drugs Product Portfolio Table 116. Actiza Pharmaceutical Recent Development Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Ringworm Treatment Drugs Distributors List Table 120. Ringworm Treatment Drugs Customers List Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Ringworm Treatment Drugs Product Image Figure 2. Global Ringworm Treatment Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ringworm Treatment Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Ringworm Treatment Drugs Sales (2021-2032) & (k units) Figure 5. Global Ringworm Treatment Drugs Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Ringworm Treatment Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Anti-infective Image Figure 10. Antifungals Image Figure 11. Steroids Image Figure 12. Others Image Figure 13. Global Ringworm Treatment Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Ringworm Treatment Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Ringworm Treatment Drugs Sales Volume Share by Type (2021-2032) Figure 16. Global Ringworm Treatment Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Ringworm Treatment Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Ringworm Treatment Drugs Sales Value Share by Type (2021-2032) Figure 19. Hospital Pharmacies Image Figure 20. Drug Stores Image Figure 21. E-commerce Image Figure 22. Other Image Figure 23. Global Ringworm Treatment Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Ringworm Treatment Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Ringworm Treatment Drugs Sales Volume Share by Application (2021-2032) Figure 26. Global Ringworm Treatment Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Ringworm Treatment Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Ringworm Treatment Drugs Sales Value Share by Application (2021-2032) Figure 29. Global Ringworm Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global Ringworm Treatment Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Ringworm Treatment Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Ringworm Treatment Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Ringworm Treatment Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. North America Ringworm Treatment Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Ringworm Treatment Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Ringworm Treatment Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Ringworm Treatment Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Ringworm Treatment Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Ringworm Treatment Drugs Sales Value (2021-2032) & (US$ Million) Figure 40. South America Ringworm Treatment Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Ringworm Treatment Drugs Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Ringworm Treatment Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Ringworm Treatment Drugs Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Ringworm Treatment Drugs Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Anti-infective
  • Antifungals
  • Steroids
  • Others
Applications
  • Hospital Pharmacies
  • Drug Stores
  • E-commerce
  • Other
Companies covered
  • Teva Pharmaceuticals, Inc.
  • Novartis AG
  • Merck & Co., In
  • GlaxoSmithKline Plc
  • Taro Ppharmaceutical Industries Ltd.
  • Perrigo Company plc
  • Glenmark Pharmaceuticals Inc.
  • Chempro Group India
  • Avik Pharma
  • Actiza Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ringworm Treatment Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Ringworm Treatment Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Ringworm Treatment Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Ringworm Treatment Drugs Market Dynamics
  1. 2.1 Ringworm Treatment Drugs Industry Trends
  2. 2.2 Ringworm Treatment Drugs Industry Drivers
  3. 2.3 Ringworm Treatment Drugs Industry Opportunities and Challenges
  4. 2.4 Ringworm Treatment Drugs Industry Restraints
3 Ringworm Treatment Drugs Market by Company
  1. 3.1 Global Ringworm Treatment Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Ringworm Treatment Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Ringworm Treatment Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Ringworm Treatment Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Ringworm Treatment Drugs Company Ranking (2024-2026)
  6. 3.6 Global Ringworm Treatment Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Ringworm Treatment Drugs Company Product Type and Application
  8. 3.8 Global Ringworm Treatment Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Ringworm Treatment Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Ringworm Treatment Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Ringworm Treatment Drugs Market by Type
  1. 4.1 Ringworm Treatment Drugs Type Introduction
  2. 4.1.1 Anti-infective
  3. 4.1.2 Antifungals
  4. 4.1.3 Steroids
  5. 4.1.4 Others
  6. 4.2 Global Ringworm Treatment Drugs Sales Volume by Type
  7. 4.2.1 Global Ringworm Treatment Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Ringworm Treatment Drugs Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Ringworm Treatment Drugs Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Ringworm Treatment Drugs Sales Value by Type
  11. 4.3.1 Global Ringworm Treatment Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Ringworm Treatment Drugs Sales Value by Type (2021-2032)
  13. 4.3.3 Global Ringworm Treatment Drugs Sales Value Share by Type (2021-2032)
5 Ringworm Treatment Drugs Market by Application
  1. 5.1 Ringworm Treatment Drugs Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Drug Stores
  4. 5.1.3 E-commerce
  5. 5.1.4 Other
  6. 5.2 Global Ringworm Treatment Drugs Sales Volume by Application
  7. 5.2.1 Global Ringworm Treatment Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Ringworm Treatment Drugs Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Ringworm Treatment Drugs Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Ringworm Treatment Drugs Sales Value by Application
  11. 5.3.1 Global Ringworm Treatment Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Ringworm Treatment Drugs Sales Value by Application (2021-2032)
  13. 5.3.3 Global Ringworm Treatment Drugs Sales Value Share by Application (2021-2032)
6 Ringworm Treatment Drugs Regional Sales and Value Analysis
  1. 6.1 Global Ringworm Treatment Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ringworm Treatment Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Ringworm Treatment Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Ringworm Treatment Drugs Sales by Region (2027-2032)
  5. 6.3 Global Ringworm Treatment Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Ringworm Treatment Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Ringworm Treatment Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Ringworm Treatment Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Ringworm Treatment Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Ringworm Treatment Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Ringworm Treatment Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Ringworm Treatment Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Ringworm Treatment Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Ringworm Treatment Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Ringworm Treatment Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Ringworm Treatment Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Ringworm Treatment Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Ringworm Treatment Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Ringworm Treatment Drugs Sales Value Share by Country, 2025 VS 2032
7 Ringworm Treatment Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Ringworm Treatment Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ringworm Treatment Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Ringworm Treatment Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Ringworm Treatment Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Ringworm Treatment Drugs Sales by Country (2027-2032)
  6. 7.4 Global Ringworm Treatment Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Ringworm Treatment Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Ringworm Treatment Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Ringworm Treatment Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Ringworm Treatment Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Ringworm Treatment Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceuticals, Inc.
  2. 8.1.1 Teva Pharmaceuticals, Inc. Company Information
  3. 8.1.2 Teva Pharmaceuticals, Inc. Business Overview
  4. 8.1.3 Teva Pharmaceuticals, Inc. Ringworm Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceuticals, Inc. Ringworm Treatment Drugs Product Portfolio
  6. 8.1.5 Teva Pharmaceuticals, Inc. Recent Developments
  7. 8.2 Novartis AG
  8. 8.2.1 Novartis AG Company Information
  9. 8.2.2 Novartis AG Business Overview
  10. 8.2.3 Novartis AG Ringworm Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novartis AG Ringworm Treatment Drugs Product Portfolio
  12. 8.2.5 Novartis AG Recent Developments
  13. 8.3 Merck & Co., In
  14. 8.3.1 Merck & Co., In Company Information
  15. 8.3.2 Merck & Co., In Business Overview
  16. 8.3.3 Merck & Co., In Ringworm Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck & Co., In Ringworm Treatment Drugs Product Portfolio
  18. 8.3.5 Merck & Co., In Recent Developments
  19. 8.4 GlaxoSmithKline Plc
  20. 8.4.1 GlaxoSmithKline Plc Company Information
  21. 8.4.2 GlaxoSmithKline Plc Business Overview
  22. 8.4.3 GlaxoSmithKline Plc Ringworm Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 GlaxoSmithKline Plc Ringworm Treatment Drugs Product Portfolio
  24. 8.4.5 GlaxoSmithKline Plc Recent Developments
  25. 8.5 Taro Ppharmaceutical Industries Ltd.
  26. 8.5.1 Taro Ppharmaceutical Industries Ltd. Company Information
  27. 8.5.2 Taro Ppharmaceutical Industries Ltd. Business Overview
  28. 8.5.3 Taro Ppharmaceutical Industries Ltd. Ringworm Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Taro Ppharmaceutical Industries Ltd. Ringworm Treatment Drugs Product Portfolio
  30. 8.5.5 Taro Ppharmaceutical Industries Ltd. Recent Developments
  31. 8.6 Perrigo Company plc
  32. 8.6.1 Perrigo Company plc Company Information
  33. 8.6.2 Perrigo Company plc Business Overview
  34. 8.6.3 Perrigo Company plc Ringworm Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Perrigo Company plc Ringworm Treatment Drugs Product Portfolio
  36. 8.6.5 Perrigo Company plc Recent Developments
  37. 8.7 Glenmark Pharmaceuticals Inc.
  38. 8.7.1 Glenmark Pharmaceuticals Inc. Company Information
  39. 8.7.2 Glenmark Pharmaceuticals Inc. Business Overview
  40. 8.7.3 Glenmark Pharmaceuticals Inc. Ringworm Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Glenmark Pharmaceuticals Inc. Ringworm Treatment Drugs Product Portfolio
  42. 8.7.5 Glenmark Pharmaceuticals Inc. Recent Developments
  43. 8.8 Chempro Group India
  44. 8.8.1 Chempro Group India Company Information
  45. 8.8.2 Chempro Group India Business Overview
  46. 8.8.3 Chempro Group India Ringworm Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Chempro Group India Ringworm Treatment Drugs Product Portfolio
  48. 8.8.5 Chempro Group India Recent Developments
  49. 8.9 Avik Pharma
  50. 8.9.1 Avik Pharma Company Information
  51. 8.9.2 Avik Pharma Business Overview
  52. 8.9.3 Avik Pharma Ringworm Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Avik Pharma Ringworm Treatment Drugs Product Portfolio
  54. 8.9.5 Avik Pharma Recent Developments
  55. 8.10 Actiza Pharmaceutical
  56. 8.10.1 Actiza Pharmaceutical Company Information
  57. 8.10.2 Actiza Pharmaceutical Business Overview
  58. 8.10.3 Actiza Pharmaceutical Ringworm Treatment Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Actiza Pharmaceutical Ringworm Treatment Drugs Product Portfolio
  60. 8.10.5 Actiza Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ringworm Treatment Drugs Value Chain Analysis
  2. 9.1.1 Ringworm Treatment Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ringworm Treatment Drugs Sales Mode & Process
  6. 9.2 Ringworm Treatment Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ringworm Treatment Drugs Distributors
  9. 9.2.3 Ringworm Treatment Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst